We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Kicks Off MDUFA V Discussions, Flags Slower Reviews During the Pandemic
FDA Kicks Off MDUFA V Discussions, Flags Slower Reviews During the Pandemic
The FDA is having trouble meeting its performance goals under the Medical Device User Fee Amendments (MDUFA) IV program due to the COVID-19 pandemic and expects the delays to increase under the public health emergency is over.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor